MedPath

Evaluating Primary Suicide Prevention in Adolescents With Risk Factors

Not Applicable
Recruiting
Conditions
Suicide Prevention
Registration Number
NCT06551038
Lead Sponsor
University of Bern
Brief Summary

Suicide is one of the main causes of death among teenagers. Because it is preventable, primary prevention of suicide has become a public health priority, with encouraging results in promoting suicide awareness and reducing suicidal thoughts among adolescents. However, the lack of studies conducted among vulnerable populations (i.e., marginalised, disengaged and disadvantaged) is a major gap, even though these populations present an increased risk of suicidal behaviour.

The aim of this project is to test the effectiveness of a brief primary suicide prevention intervention for vulnerable adolescents, using a randomised controlled trial. Vulnerable adolescents include those 1) detained in juvenile detention centres, 2) at risk of dropping out of school, 3) undergoing treatment for psychiatric disorders, and 4) belonging to a sexual or gender minority. The main aim is to test the effectiveness of the intervention on a composite measure of suicide awareness, psychological distress and suicidal thoughts. The project will also explore other issues that present challenges for vulnerable populations: access to primary suicide prevention and non-response bias. The study will provide relevant results to address the current lack of high-quality evidence for primary suicide prevention in adolescents.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
240
Inclusion Criteria
  • Vulnerable adolescents defined as being: 1) detained in juvenile detention centers, 2) disconnected from school, 3) in treatment for psychiatric disorders, or 4) belonging to a sexual or gender minority.
  • Age 14 to 18 years old.
  • Good knowledge of French.
  • Accepting to sign the informed consent.
Exclusion Criteria
  • The medical/educational staff considers that the intervention will interfere with appropriate management of acute psychiatric disorder or may cause harm to self or other.
  • Being enrolled in another suicide prevention intervention during the study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite measure of suicide awarenessOne-week post-baseline

Nine-item perceived suicide awareness scale (PSAS-9), assessed on a 5-point scale, score ranging from 0 to 36, with a higher score indicating a higher suicide awareness

Secondary Outcome Measures
NameTimeMethod
Knowledge of local resourcesOne-week post-baseline; six-month post-baseline

Self-developed scale on local resources, 6 binary (true/false) questions, score ranging from 0 to 6, with a higher score indicating higher knowledge of local resources

Composite measure of suicide awarenessSix-month post-baseline

Nine-item perceived suicide awareness scale (PSAS-9), assessed on a 5-point scale, score ranging from 0 to 36, with a higher score indicating a higher suicide awareness

Knowledge on suicideOne-week post-baseline; six-month post-baseline

Literacy of Suicide Scale (LOSS), 12 binary (true/false) questions, score ranging from 0 to 12, with a higher score indicating higher knowledge on suicide

Suicidal thoughtsOne-week post-baseline; six-month post-baseline

Suicidal Ideation Attributes Scale (SIDAS), 10 questions assessed on a 5-point scale, with a score ranging from 0 to 50. A higher score indicates a higher level of suicidal thoughts.

Psychological distressOne-week post-baseline; six-month post-baseline

Kessler Psychological Distress scale (K-6), 6-item scale is assessed on a 5-point scale, with a score ranging from 0 to 24. A higher score indicates a higher level of psychological distress.

Access to primary suicide preventionBaseline

Self-developed scale on primary suicide prevention training, 3 questions combined in a binary indicator (yes/no)

AttritionSix-month post-baseline

Percentage of participants who drop out, continuous variable (0-100), with a higher percentage indicating a higher level of attrition

Trial Locations

Locations (10)

Programme ForMe (anciennement SEMO) et dispositif ProPULSE

🇨🇭

Plan-les-Ouates, Geneva, Switzerland

Centre de Détention et d'Observation La Clairière

🇨🇭

Vernier, Geneva, Switzerland

Programme Intégration et Formation Professionnelle

🇨🇭

Vernier, Geneva, Switzerland

Centre éducatif fermé de Pramont

🇨🇭

Sierre, Valais, Switzerland

Agnodice

🇨🇭

Lausanne, Vaud, Switzerland

Vogay

🇨🇭

Lausanne, Vaud, Switzerland

Centre Thérapeutique de Jour pour Adolescents

🇨🇭

Lausanne, Vaud, Switzerland

Unité de Soins Psychiatriques Fermée pour Mineurs

🇨🇭

Lausanne, Vaud, Switzerland

Établissement de Détention pour mineurs et jeunes adultes Les Léchaires

🇨🇭

Palézieux, Vaud, Switzerland

Dialogai et Totem

🇨🇭

Geneva, Switzerland

Programme ForMe (anciennement SEMO) et dispositif ProPULSE
🇨🇭Plan-les-Ouates, Geneva, Switzerland
Nadejda Lambert
Contact
+41223205567
nadejda@stopsuicide.ch

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.